Generic EpiPen Could Still Be Costly for Families - WJBD Online

WJBD OnlineGeneric EpiPen Could Still Be Costly for FamiliesWJBD OnlineA study published in the Journal of the American Medical Association last week that examined U.S. drug prices found multiple reasons for high drug prices in the U.S. including patents on name-brand drugs and limited negotiating power for the consumer.Fabregas: Mylan needs to overturn Epipen cash grabTribune-ReviewMylan to Launch Generic Version of EpiPenPharmaceutical Technology Magazine (press release) (blog)EpiPen maker's cheaper version aims to quell furor in USCBC.caMed Device Online (press release) -The Chronicle Journal -Cantech Letterall 617 news articles »